MJMD Stock News 0.8600 05/06/2014 15:02:37 Medijane Holdings
Post# of 273378
Posted On: 05/06/2014 4:02:29 PM
Medijane Holdings Inc (MJMD) 0.8600 $MJMD
Botanist and Product Formulator Pamela Clum First Addition to MediJane Holdings Advisory Board
Marketwire - Fri May 02, 5:01AM CDT
MediJane Holdings Inc. (OTCQB: MJMD) ("MediJane" or "MJMD" or the "Company"
is pleased to announce that Pamela Clum has joined the newly formed Advisory Board of the Company.
MediJane Holdings begins California Expansion Strategy
Marketwire - Tue Apr 29, 5:01AM CDT
MediJane Holdings Inc. (OTCQB: MJMD) ("MediJane" or "MJMD" or the "Company" is pleased to announce that the Company has begun its planned California expansion strategy.
Lewis "Spike" Humer Steps Up as New Chairman of MediJane Holdings
Marketwire - Fri Apr 25, 9:30AM CDT
MediJane Holdings Inc. (OTCQB: MJMD) ("MediJane" or "MJMD" or the "Company" is pleased to announce that Lewis "Spike" Humer has been named as Chairman and Director of Company. Mr. Humer is also currently CEO of Phoenix Bio Pharmaceuticals Corporation ("Phoenix Bio Pharm", the Colorado-based developer of certain medicinal cannabis products and delivery systems exclusively licensed to MediJane Holdings in North America.
Dr. Joseph Cohen Appointed as Chief Medical Officer of MediJane Holdings
Marketwire - Wed Apr 16, 7:31AM CDT
MediJane Holdings Inc. (OTCQB: MJMD) ("MediJane" or "MJMD" or the "Company" is pleased to announce that Dr. Joseph Cohen has agreed to assume the role of Chief Medical Officer and join the board of directors of the Company.
MediJane Holdings Retains Peacock Meyers for IP and Trademark Protection
Marketwire - Thu Apr 10, 7:31AM CDT
MediJane Holdings Inc. (OTCQB: MJMD) ("MediJane" or "MJMD" or the "Company" is pleased to announce that it has retained the services of patent and intellectual property law firm Peacock Meyers, P.C. ("Peacock Meyers" to file all necessary and requisite documents with the United States Patent and Trademark Office (USPTO) to secure the trademark "MediJane" or any combination as it applies to the medical marijuana industry.
MediJane Holdings Joins the National Cannabis Industry Association
Marketwire - Fri Mar 28, 3:15PM CDT
MediJane Holdings Inc. (OTCQB: MJMD) ("MediJane" or "MJMD" or the "Company" is pleased to announce that it has become a member and sponsor of the National Cannabis Industry Association (NCIA).
MediJane Holdings Inc. Makes Strong Foray into the Medical-Marijuana Business
ACCESSWIRE - Mon Mar 24, 8:56AM CDT
MediJane Holdings Inc. (OTCQB: MJMD) stock volume surged Mar. 21, with 793,961 shares changing hands, more than four times its three-month average volume of 185,325 shares.
MediJane Holdings Inc. Discusses Mission Statement and Growth Strategies Within Medicinal Marijuana Sector
Marketwire - Mon Mar 24, 6:01AM CDT
MediJane Holdings Inc. (OTCQB: MJMD) ("MediJane" or "MJMD" or the "Company" is pleased to provide this discussion regarding its recent acquisition of the exclusive North American license to certain medicinal cannabis products and delivery systems developed by Colorado-based Phoenix Bio Pharmaceuticals Corporation ("Phoenix Bio Pharm". In addition, this licensing agreement should allow MediJane to enhance Phoenix Bio Pharm's established relationships with physicians, scientists, product developers, biochemists, botanists, pharmacists, operators of growing facilities, dispensaries, and production facilities within the pharmaceutical and medical cannabis industries.
MediJane Holdings OTCQB MJMD the latest entry into the medical marijuana industry share price off 10% on news
M2 - Fri Mar 21, 9:50AM CDT
March 21,2014 Vancouver (321gostocks) MediJane Holdings Inc. (OTCQB: MJMD) ("MediJane" or "MJMD" or the "Company" is pleased to announce that it has entered into a License Agreement with Phoenix Bio Pharmaceuticals Corporation ("Phoenix Bio Pharm", a Colorado-based developer of medicinal cannabinoid products and delivery systems for the treatment and management of illnesses.
MediJane Holdings Inc. Enters Medicinal Marijuana Sector With Phoenix Bio Pharm License Agreement
Marketwire - Fri Mar 21, 7:01AM CDT
MediJane Holdings Inc. (OTCQB: MJMD) ("MediJane" or "MJMD" or the "Company" is pleased to announce that it has entered into a License Agreement with Phoenix Bio Pharmaceuticals Corporation ("Phoenix Bio Pharm", a Colorado-based developer of medicinal cannabinoid products and delivery systems for the treatment and management of illnesses.
Botanist and Product Formulator Pamela Clum First Addition to MediJane Holdings Advisory Board
Marketwire - Fri May 02, 5:01AM CDT
MediJane Holdings Inc. (OTCQB: MJMD) ("MediJane" or "MJMD" or the "Company"
is pleased to announce that Pamela Clum has joined the newly formed Advisory Board of the Company. MediJane Holdings begins California Expansion Strategy
Marketwire - Tue Apr 29, 5:01AM CDT
MediJane Holdings Inc. (OTCQB: MJMD) ("MediJane" or "MJMD" or the "Company"
is pleased to announce that the Company has begun its planned California expansion strategy. Lewis "Spike" Humer Steps Up as New Chairman of MediJane Holdings
Marketwire - Fri Apr 25, 9:30AM CDT
MediJane Holdings Inc. (OTCQB: MJMD) ("MediJane" or "MJMD" or the "Company"
is pleased to announce that Lewis "Spike" Humer has been named as Chairman and Director of Company. Mr. Humer is also currently CEO of Phoenix Bio Pharmaceuticals Corporation ("Phoenix Bio Pharm", the Colorado-based developer of certain medicinal cannabis products and delivery systems exclusively licensed to MediJane Holdings in North America. Dr. Joseph Cohen Appointed as Chief Medical Officer of MediJane Holdings
Marketwire - Wed Apr 16, 7:31AM CDT
MediJane Holdings Inc. (OTCQB: MJMD) ("MediJane" or "MJMD" or the "Company"
is pleased to announce that Dr. Joseph Cohen has agreed to assume the role of Chief Medical Officer and join the board of directors of the Company. MediJane Holdings Retains Peacock Meyers for IP and Trademark Protection
Marketwire - Thu Apr 10, 7:31AM CDT
MediJane Holdings Inc. (OTCQB: MJMD) ("MediJane" or "MJMD" or the "Company"
is pleased to announce that it has retained the services of patent and intellectual property law firm Peacock Meyers, P.C. ("Peacock Meyers" to file all necessary and requisite documents with the United States Patent and Trademark Office (USPTO) to secure the trademark "MediJane" or any combination as it applies to the medical marijuana industry. MediJane Holdings Joins the National Cannabis Industry Association
Marketwire - Fri Mar 28, 3:15PM CDT
MediJane Holdings Inc. (OTCQB: MJMD) ("MediJane" or "MJMD" or the "Company"
is pleased to announce that it has become a member and sponsor of the National Cannabis Industry Association (NCIA). MediJane Holdings Inc. Makes Strong Foray into the Medical-Marijuana Business
ACCESSWIRE - Mon Mar 24, 8:56AM CDT
MediJane Holdings Inc. (OTCQB: MJMD) stock volume surged Mar. 21, with 793,961 shares changing hands, more than four times its three-month average volume of 185,325 shares.
MediJane Holdings Inc. Discusses Mission Statement and Growth Strategies Within Medicinal Marijuana Sector
Marketwire - Mon Mar 24, 6:01AM CDT
MediJane Holdings Inc. (OTCQB: MJMD) ("MediJane" or "MJMD" or the "Company"
is pleased to provide this discussion regarding its recent acquisition of the exclusive North American license to certain medicinal cannabis products and delivery systems developed by Colorado-based Phoenix Bio Pharmaceuticals Corporation ("Phoenix Bio Pharm". In addition, this licensing agreement should allow MediJane to enhance Phoenix Bio Pharm's established relationships with physicians, scientists, product developers, biochemists, botanists, pharmacists, operators of growing facilities, dispensaries, and production facilities within the pharmaceutical and medical cannabis industries. MediJane Holdings OTCQB MJMD the latest entry into the medical marijuana industry share price off 10% on news
M2 - Fri Mar 21, 9:50AM CDT
March 21,2014 Vancouver (321gostocks) MediJane Holdings Inc. (OTCQB: MJMD) ("MediJane" or "MJMD" or the "Company"
is pleased to announce that it has entered into a License Agreement with Phoenix Bio Pharmaceuticals Corporation ("Phoenix Bio Pharm", a Colorado-based developer of medicinal cannabinoid products and delivery systems for the treatment and management of illnesses. MediJane Holdings Inc. Enters Medicinal Marijuana Sector With Phoenix Bio Pharm License Agreement
Marketwire - Fri Mar 21, 7:01AM CDT
MediJane Holdings Inc. (OTCQB: MJMD) ("MediJane" or "MJMD" or the "Company"
is pleased to announce that it has entered into a License Agreement with Phoenix Bio Pharmaceuticals Corporation ("Phoenix Bio Pharm", a Colorado-based developer of medicinal cannabinoid products and delivery systems for the treatment and management of illnesses. 
(0)
(0)